{"entity":{"type":"insider","cik":"0001768239","url":"/insider/0001768239","json_url":"/insider/0001768239.json","name":"Thomas Dolca","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2019-12-20","last":"2022-09-06","span_basis":"filed_date"},"name_variants":[{"name":"Thomas Dolca","source":"filing","n_filings":4,"first_seen":"2019-12-20","last_seen":"2022-09-06"}],"transactions":[{"id":6657891,"accession":"0001209191-22-048759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048759","line_url":"/filing/0001209191-22-048759","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001768239","owner_name":"Thomas Dolca","owner_display_name":"Thomas Dolca","owner_url":"/insider/0001768239","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":21.2194,"price_display":"21.22","price_state":"stated","total_value":212194.0,"total_display":"212,194.00","total_whole":"212,194","shares_owned_after":9700.0,"shares_owned_after_display":"9,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":3046590,"accession":"0001209191-20-047842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047842","line_url":"/filing/0001209191-20-047842#line-2","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001768239","owner_name":"Thomas Dolca","owner_display_name":"Thomas Dolca","owner_url":"/insider/0001768239","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":1826.0,"shares_owned_after_display":"1,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2141398,"accession":"0001209191-20-043008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043008","line_url":"/filing/0001209191-20-043008#line-2","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001768239","owner_name":"Thomas Dolca","owner_display_name":"Thomas Dolca","owner_url":"/insider/0001768239","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":80.0713,"price_display":"80.07","price_state":"stated","total_value":1201069.5,"total_display":"1,201,069.50","total_whole":"1,201,070","shares_owned_after":1826.0,"shares_owned_after_display":"1,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":7885936,"accession":"0001209191-19-061667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-061667","line_url":"/filing/0001209191-19-061667#line-1","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001768239","owner_name":"Thomas Dolca","owner_display_name":"Thomas Dolca","owner_url":"/insider/0001768239","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":495.0,"shares_display":"495","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":29700.0,"total_display":"29,700.00","total_whole":"29,700","shares_owned_after":494.0,"shares_owned_after_display":"494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Director","n_filings":1,"first_seen":"2022-09-06","last_seen":"2022-09-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Officer (Chief Medical Officer)","n_filings":3,"first_seen":"2019-12-20","last_seen":"2020-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001768239","retrieved_at":"2026-08-26T03:23:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}